Lanatoside C displayed a potent inhibitory effect on key target proteins of Wnt signaling, i.e., GSK-3α and β-catenin in Lanatoside C treated breast, lung, and liver cancer cells. The gene discussed is GSK3A; the disease is liver cancer.